ProQinase is a preclinical CRO dedicated to support the development of cancer therapeutics by providing customized solutions that cover the full range of services from hit identification to preclinical testing.
ProQinase’s portfolio includes biochemical kinase assays, cell-based assays, and in vivo tumor models. We continuously work to extend these services and, in addition, offers custom-tailored assay development to provide state-of-the-art drug discovery service.